419 related articles for article (PubMed ID: 22045654)
1. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats.
Soetikno V; Watanabe K; Sari FR; Harima M; Thandavarayan RA; Veeraveedu PT; Arozal W; Sukumaran V; Lakshmanan AP; Arumugam S; Suzuki K
Mol Nutr Food Res; 2011 Nov; 55(11):1655-65. PubMed ID: 22045654
[TBL] [Abstract][Full Text] [Related]
2. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
[TBL] [Abstract][Full Text] [Related]
3. Effect of catalpol on diabetic nephropathy in rats.
Dong Z; Chen CX
Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
7. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB.
Chiu J; Khan ZA; Farhangkhoee H; Chakrabarti S
Nutrition; 2009 Sep; 25(9):964-72. PubMed ID: 19268536
[TBL] [Abstract][Full Text] [Related]
8. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
9. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
[TBL] [Abstract][Full Text] [Related]
10. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats.
Anjaneyulu M; Chopra K
Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):244-8. PubMed ID: 15053821
[TBL] [Abstract][Full Text] [Related]
11. Esculetin induced changes in Mmp13 and Bmp6 gene expression and histone H3 modifications attenuate development of glomerulosclerosis in diabetic rats.
Surse VM; Gupta J; Tikoo K
J Mol Endocrinol; 2011 Jun; 46(3):245-54. PubMed ID: 21450970
[TBL] [Abstract][Full Text] [Related]
12. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.
Ohshiro Y; Ma RC; Yasuda Y; Hiraoka-Yamamoto J; Clermont AC; Isshiki K; Yagi K; Arikawa E; Kern TS; King GL
Diabetes; 2006 Nov; 55(11):3112-20. PubMed ID: 17065350
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice.
Elmarakby AA; Ibrahim AS; Faulkner J; Mozaffari MS; Liou GI; Abdelsayed R
Vascul Pharmacol; 2011; 55(5-6):149-56. PubMed ID: 21807121
[TBL] [Abstract][Full Text] [Related]
14. Diltiazem attenuates oxidative stress in diabetic rats.
Anjaneyulu M; Chopra K
Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
[TBL] [Abstract][Full Text] [Related]
15. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
[TBL] [Abstract][Full Text] [Related]
16. N-hexacosanol ameliorates streptozotocin-induced diabetic rat nephropathy.
Saito M; Kinoshita Y; Satoh I; Shinbori C; Kono T; Hanada T; Uemasu J; Suzuki H; Yamada M; Satoh K
Eur J Pharmacol; 2006 Aug; 544(1-3):132-7. PubMed ID: 16859672
[TBL] [Abstract][Full Text] [Related]
17. Nordihydroguairetic acid, a lignin, prevents oxidative stress and the development of diabetic nephropathy in rats.
Anjaneyulu M; Chopra K
Pharmacology; 2004 Sep; 72(1):42-50. PubMed ID: 15292654
[TBL] [Abstract][Full Text] [Related]
18. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
19. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
Lai PB; Zhang L; Yang LY
Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
[TBL] [Abstract][Full Text] [Related]
20. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling.
Kuo CW; Shen CJ; Tung YT; Chen HL; Chen YH; Chang WH; Cheng KC; Yang SH; Chen CM
Life Sci; 2015 Aug; 135():77-86. PubMed ID: 26006040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
